SI-BONE To Report Second Quarter 2024 Financial Results on August 5, 2024

Rhea-AI Summary

SI-BONE, Inc. (Nasdaq: SIBN), a medical device company focused on musculoskeletal disorders of the sacropelvic anatomy, has announced it will release its second quarter 2024 financial results on August 5, 2024, after market close. The company will host a conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on the same day to discuss the results. Investors can register for the call using the provided link. A live audio webcast will be available on the company's website, and a replay will be accessible for at least 90 days after the event.

SANTA CLARA, Calif., July 15, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the second quarter of 2024 after market close on Monday, August 5, 2024. Management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Investors interested in listening to the conference call may do so by registering at this link: https://edge.media-server.com/mmc/p/bdg2s7zw. Live audio of the webcast will be available on the “Investors” section of the company’s website at: www.si-bone.com. The webcast will be archived and available for replay for at least 90 days after the event.

About SI-BONE, Inc.

SI-BONE (NASDAQ: SIBN) is a global leader in technology for surgical treatment of musculoskeletal disorders of the sacropelvic anatomy. Since pioneering minimally invasive surgery of the SI joint in 2009, SI-BONE has supported over 3,700 surgeons in performing a total of more than 100,000 sacropelvic procedures. A unique body of clinical evidence supports the use of SI-BONE’s technologies, including four randomized controlled trials and over 130 peer reviewed publications. SI-BONE has leveraged its leadership in minimally invasive SI joint fusion to commercialize novel solutions for adjacent markets, including adult deformity, spinopelvic fixation, and pelvic trauma.

For additional information on the company or the products including risks and benefits, please visit www.si-bone.com.

iFuse Bedrock Granite, iFuse-TORQ, SI-BONE and iFuse INTRA are registered trademarks of SI-BONE, Inc. ©2024 SI-BONE, Inc. All Rights Reserved.

Investor Contact: Saqib Iqbal investors@si-bone.com

FAQ

When will SI-BONE (SIBN) report its Q2 2024 financial results?

SI-BONE (SIBN) will report its second quarter 2024 financial results on August 5, 2024, after market close.

What time is SI-BONE's (SIBN) Q2 2024 earnings conference call scheduled for?

SI-BONE's (SIBN) Q2 2024 earnings conference call is scheduled for 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on August 5, 2024.

How can investors access SI-BONE's (SIBN) Q2 2024 earnings call?

Investors can access SI-BONE's (SIBN) Q2 2024 earnings call by registering through the provided link or listening to the live audio webcast on the 'Investors' section of the company's website.

How long will the replay of SI-BONE's (SIBN) Q2 2024 earnings call be available?

The replay of SI-BONE's (SIBN) Q2 2024 earnings call will be archived and available for at least 90 days after the event on the company's website.